The regulatory role of androgen as well as AR signaling in the autophagic process has been already known as one of the key mechanisms involved in the transition of prostate cancer cells from an androgen-dependent to an androgen-independent cell type [25,26], and targeting autophagy was observed to overcome Enzalutamide resistance in CRPC [27]. This evidence concerns the gene AR and prostate cancer.